KR20010042322A - 막-유형 매트릭스 메탈로프로테인아제를 억제하는 방법 - Google Patents

막-유형 매트릭스 메탈로프로테인아제를 억제하는 방법 Download PDF

Info

Publication number
KR20010042322A
KR20010042322A KR1020007010871A KR20007010871A KR20010042322A KR 20010042322 A KR20010042322 A KR 20010042322A KR 1020007010871 A KR1020007010871 A KR 1020007010871A KR 20007010871 A KR20007010871 A KR 20007010871A KR 20010042322 A KR20010042322 A KR 20010042322A
Authority
KR
South Korea
Prior art keywords
cmt
tetracycline
mmp
activity
dimethylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020007010871A
Other languages
English (en)
Korean (ko)
Inventor
골룹론엠
리시-밍
조르자티모
테로넨올리
잘로투울라
Original Assignee
제임스 알. 데니히
더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제임스 알. 데니히, 더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕 filed Critical 제임스 알. 데니히
Publication of KR20010042322A publication Critical patent/KR20010042322A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020007010871A 1998-03-31 1999-03-30 막-유형 매트릭스 메탈로프로테인아제를 억제하는 방법 Ceased KR20010042322A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9/052,222 1998-03-31
US09/052,222 US6277061B1 (en) 1998-03-31 1998-03-31 Method of inhibiting membrane-type matrix metalloproteinase
PCT/US1999/006972 WO1999049871A1 (en) 1998-03-31 1999-03-30 Method of inhibiting membrane-type matrix metalloproteinase

Publications (1)

Publication Number Publication Date
KR20010042322A true KR20010042322A (ko) 2001-05-25

Family

ID=21976191

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007010871A Ceased KR20010042322A (ko) 1998-03-31 1999-03-30 막-유형 매트릭스 메탈로프로테인아제를 억제하는 방법

Country Status (8)

Country Link
US (2) US6277061B1 (enExample)
EP (1) EP1079837A4 (enExample)
JP (1) JP2002509889A (enExample)
KR (1) KR20010042322A (enExample)
AU (1) AU748870B2 (enExample)
CA (1) CA2320260A1 (enExample)
NZ (1) NZ506153A (enExample)
WO (1) WO1999049871A1 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506740B1 (en) * 1998-11-18 2003-01-14 Robert A. Ashley 4-dedimethylaminotetracycline derivatives
EP1174129A1 (en) * 2000-07-17 2002-01-23 Zenner, Hans Peter, Prof. Dr. med. Use of a matrix-metalloprotease inhibitor for the treatment of cancer
EP2329826A1 (en) 2001-07-13 2011-06-08 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of multiple sclerosis
CA2462572C (en) * 2001-10-05 2008-11-18 Tetragenex Pharmaceuticals, Inc. Tetracycline derivatives and methods of use thereof
IL162213A0 (en) * 2001-12-03 2005-11-20 Novacea Inc Pharmaceutical compositions containing active vitamin d compounds
WO2003053447A1 (en) * 2001-12-20 2003-07-03 Hanauske-Abel Hartmut M Treatment for averting or delaying premature delivery
EP2322501B1 (en) 2002-01-08 2015-08-05 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
KR101014918B1 (ko) 2002-03-08 2011-02-15 파라테크 파마슈티컬스, 인크. 아미노-메틸 치환된 테트라시클린 화합물
EP2481723A3 (en) 2002-03-21 2013-02-13 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EP2250887B1 (en) * 2002-03-29 2013-04-24 The Research Foundation Of The State University Of New York Use of non-antibacterial tetracycline analog CMT-1002 and formulations thereof for the treatment of bacterial exotoxins
EP2345637A3 (en) 2002-07-12 2012-02-15 Paratek Pharmaceuticals, Inc. 3, 10, and 12a substituted tetracycline compounds
US20040170621A1 (en) * 2002-08-30 2004-09-02 Roodman G. David Method of resisting osteoclast formation
US20040138162A1 (en) * 2002-08-30 2004-07-15 Roodman G. David Method of resisting osteoclast formation
EP1562608A4 (en) 2002-10-24 2010-09-01 Paratek Pharm Innc METHOD OF USE OF SUBSTITUTED TETRACYCLINE COMPOUNDS FOR MODULATING THE RNA
CA2511521C (en) 2002-12-30 2012-02-07 Angiotech International Ag Drug delivery from rapid gelling polymer composition
CA2531728A1 (en) 2003-07-09 2005-02-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
JP4738333B2 (ja) 2003-07-09 2011-08-03 パラテック ファーマシューティカルズ インコーポレイテッド ９−アミノメチルテトラサイクリン化合物のプロドラッグ
WO2005070878A1 (en) * 2004-01-15 2005-08-04 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
EP1805134B1 (en) 2004-10-25 2012-06-20 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
EP2269978A3 (en) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
WO2007014154A2 (en) * 2005-07-21 2007-02-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
US20070142337A1 (en) * 2005-12-15 2007-06-21 The Regents Of The University Of California Treatment of inflammation and organ dysfunction
IL302749A (en) 2006-12-21 2023-07-01 Paratek Pharm Innc A tetracycline compound, a pharmaceutical preparation containing the tetracycline compound, and the tetracycline compound or the pharmaceutical preparation for the treatment of the tetracycline-responsive condition
TR201818983T4 (tr) * 2006-12-21 2019-01-21 Paratek Pharm Innc İnflamatuvar Cilt Bozukluklarının Tedavisine Yönelik Olarak Sübstitüe Edilmiş Tetrasiklin Bileşikleri
EP2213655A1 (en) 2007-04-27 2010-08-04 Paratek Pharmaceuticals, Inc. Methods For Purifying Aminoalkyl Tetracycline Compounds
CN101811980A (zh) * 2007-07-06 2010-08-25 帕拉特克药品公司 合成取代的四环素化合物的方法
TW202216656A (zh) 2008-05-19 2022-05-01 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
CN105367440A (zh) 2008-08-08 2016-03-02 四相制药公司 C7-氟取代的四环素化合物
CN102459153A (zh) 2009-05-08 2012-05-16 四相制药公司 四环素类化合物
PL2470500T3 (pl) 2009-08-28 2018-03-30 Tetraphase Pharmaceuticals, Inc. Związki tetracyklinowe
JP5820462B2 (ja) 2010-03-31 2015-11-24 テトラフェース ファーマシューティカルズ，インコーポレイテッド 多環式テトラサイクリン化合物
HRP20191295T8 (hr) 2011-05-12 2020-02-07 Paratek Pharmaceuticals, Inc. Kristalne soli amida (4s,4as,5ar,12as)-4-dimetilamino-3,10,12,12a-tetrahidroksi-7-[(metoksi(metil)amino)-metil]-1,11-diokso-1,4,4a,5,5a,6,11,12a-oktahidro-naftacen-2-karboksilne kiseline i postupci uporabe istih
SMT201900096T1 (it) 2012-08-31 2019-02-28 Tetraphase Pharmaceuticals Inc Composti di tetracicline
JP7492335B2 (ja) 2016-10-19 2024-05-29 テトラフェース ファーマシューティカルズ，インコーポレイテッド エラバサイクリンの結晶形
WO2020097450A1 (en) 2018-11-09 2020-05-14 Tetraphase Pharmaceuticals, Inc. Polymorphic forms of a compound and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4925833A (en) * 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
WO1992012717A2 (en) 1991-01-15 1992-08-06 A composition containing a tetracycline and use for inhibiting angiogenesis
DE69304292T2 (de) * 1992-11-17 1997-01-02 Univ New York Tetracycline inclusive nicht antimicrobiel wirksame, chemisch modifizierte Tetracycline hemmende exzessive Kollagenquervernetzung bei Diabetes
US5668122A (en) * 1993-07-28 1997-09-16 Fife; Rose S. Method to treat cancer with tetracyclines
GB9615976D0 (en) 1996-07-30 1996-09-11 Center For Clinical & Basic Re The use of proteinase inhibitors for the prevention or reduction of bone resorption
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5837696A (en) 1997-01-15 1998-11-17 The Research Foundation Of State University Of New York Method of inhibiting cancer growth

Also Published As

Publication number Publication date
AU3457699A (en) 1999-10-18
WO1999049871A8 (en) 1999-12-02
EP1079837A4 (en) 2003-07-02
US20020045603A1 (en) 2002-04-18
EP1079837A1 (en) 2001-03-07
NZ506153A (en) 2003-10-31
US6277061B1 (en) 2001-08-21
CA2320260A1 (en) 1999-10-07
JP2002509889A (ja) 2002-04-02
WO1999049871A1 (en) 1999-10-07
AU748870B2 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
KR20010042322A (ko) 막-유형 매트릭스 메탈로프로테인아제를 억제하는 방법
JP4428727B2 (ja) 癌の成長を抑制する方法
ES2237945T3 (es) Combinacion de bisfosfonato y tetraciclina.
US6384081B2 (en) Treatment of diseases of the eye characterized by the formation of metalloproteinase
ES2241124T3 (es) Actividad inhibidora de serin-proteinasa mediante tetraciclina hidrofoba.
KR100518106B1 (ko) 혈관신생 예방 및 악성종양 치료용 퀴나졸리논-함유 약제학적 조성물
Lee et al. CMT-3, a non-antimicrobial tetracycline (TC), inhibits MT1-MMP activity: relevance to cancer
Hagmann et al. Inhibition of matrix metalloproteinases.
US6429204B1 (en) Method of inhibiting cancer growth
JP2002506881A (ja) 新規マトリックスメタロプロテイナーゼ阻害剤および下方調節剤
JP4630661B2 (ja) 線維症および瘢痕形成の治療におけるコンバターゼインヒビターの使用
US5925350A (en) Use of preparation comprising a plasminogen activator to improve wound healing
JP2002537268A (ja) 結合組織の軟化
Hanemaaijer et al. Inhibition of matrix metalloproteinases (MMPs) by tetracyclines
US10046053B2 (en) Protease triggered release of molecules from hydrogels
MXPA99006554A (en) Method of inhibiting cancer growth
US20180311364A1 (en) Protease Triggered Release Of Molecules From Hydrogels
Acid Correlation of Antiangiogenic and Antitumor Efficacy of
WO1996016648A1 (en) Method for regulating metalloproteinase activity
Hagmann SmithKline Beecham Pharmaceuticals2, King of Prussia, PA19406
Anand Function and Regulation of Matrix Metalloproteinase-1 in Glioblastoma Multiforme

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20000929

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20040329

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20051209

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20060518

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20051209

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20060818

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20060518

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20070725

Appeal identifier: 2006101007268

Request date: 20060818

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20060818

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20060818

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20060309

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20040329

Patent event code: PB09011R02I

B601 Maintenance of original decision after re-examination before a trial
PB0601 Maintenance of original decision after re-examination before a trial
J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20060818

Effective date: 20070725

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20070725

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20060818

Decision date: 20070725

Appeal identifier: 2006101007268